Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (beijing) Co., Ltd.

Clinical trials sponsored by Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (beijing) Co., Ltd., explained in plain language.

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

First human test for kidney disease drug seeks safety clues

Knowledge-focused Not yet recruiting

This is an early safety study for a new injection called RG002C0106, which is being developed for IgA nephropathy, a kidney disease. The main goal is to see how the drug is processed by the body in people with healthy kidneys compared to those with mild or moderate kidney problem…

Phase: PHASE1 • Sponsor: Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd. • Aim: Knowledge-focused

Last updated Mar 30, 2026 14:30 UTC